TXO:NYSETXO Partners, L.P. Analysis
Data as of 2026-09-18 - not real-time
$14.64
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind TXO Partners, L.P. is bullish at $14.64, with short-term averages leading the long-term ones. The last 30 days have gained 7.8%. RSI sits at 51.1, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $13.90 up to resistance at $15.58.
Multiples put this in undervalued territory: 12.9 times earnings against the sector's 17.9. Sell-side targets cluster 29.8% above the current quote. Revenue is growing at 67.9% on a -9.2% profit margin. The 9.53% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 28.4%, a beta of -0.20 and a maximum drawdown of 30.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.
Multiples put this in undervalued territory: 12.9 times earnings against the sector's 17.9. Sell-side targets cluster 29.8% above the current quote. Revenue is growing at 67.9% on a -9.2% profit margin. The 9.53% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 28.4%, a beta of -0.20 and a maximum drawdown of 30.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.
Top Market Events
Seeking Alpha1monTXO Partners: Looking Great Ahead Of Q2 EarningsTXO Partners is upgraded from Buy to Strong Buy,...TXO, CBRL and GRMN made it to the Zacks Rank 1 Strong Buy income stocks list on September 4, 2026.Business Wire1monTXO Partners Declares a Second Quarter 2026 Distribution of $0.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 12.66
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 12.9 versus sector average of 17.9
- Dividend yield of 9.53% looks stretched against payout coverage
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 12.9 versus sector average of 17.9
- Dividend yield of 9.53% looks stretched against payout coverage
- Negative profit margin of -9.2%
Key Metrics & Analysis
Financial Health
Revenue Growth67.90%
Profit Margin-9.23%
P/E Ratio12.9
ROE-5.35%
ROA-2.35%
Debt/Equity41.68
P/B Ratio1.2
Op. Cash Flow$143.2M
Free Cash Flow$-87281504
Industry P/E17.9
Technical Analysis
TrendBullish
RSI51.1
Support$13.90
Resistance$15.58
MA 20$14.76
MA 50$13.93
MA 200$12.66
MACDBearish
VolumeIncreasing
Fear & Greed Index94.32
Valuation
Fair Value$57.29
Target Price$19.00
Upside/Downside29.78%
GradeUndervalued
TypeValue
Dividend Yield9.53%
Risk Assessment
Beta-0.20
Volatility28.42%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.